Four-year outcomes after percutaneous coronary intervention of unprotected left main coronary artery disease in patients with stable angina and acute coronary syndrome
- PMID: 33565302
- DOI: 10.2478/rjim-2020-0042
Four-year outcomes after percutaneous coronary intervention of unprotected left main coronary artery disease in patients with stable angina and acute coronary syndrome
Abstract
Background. Percutaneous coronary intervention (PCI) of unprotected left main coronary artery disease (ULMCAD) have become a feasible and efficient alternative to coronary artery bypass surgery, especially in patients with acute coronary syndrome (ACS). There are limited data regarding early and late outcomes after ULMCAD PCI in patients with ACS and stable angina.The aim of this study was to compare early and four-year clinical outcomes in patients with ULMCAD PCI presenting as ACS or stable angina in a high-volume PCI center.Methods. We conducted a single center retrospective observational study, which included 146 patients with ULMCAD undergoing PCI between 2014 and 2018. Patients were divided in two groups: Group A included patients with stable angina (n = 70, 47.9%) and Group B patients with ACS (n = 76, 52.1%).Results. 30-day mortality was 8.22% overall, lower in Group A (1.43% vs 14.47%, p = 0.02). Mortality and major adverse cardiac events (MACE) rates at 4 years were significantly lower in Group A (9.64% vs 33.25%, p = 0.001, and 24.06% vs 40.11%, p = 0.012, respectively). Target lesion revascularization (TLR) at 4 year did not differ between groups (15% in Group A vs 12.76% in Group B, p = 0.5).Conclusions. In our study patients with ULMCAD and ACS undergoing PCI had higher early and long-term mortality and MACE rates compared to patients with stable angina, with similar TLR rate at 4-year follow-up.
Keywords: acute coronary syndrome; left main stenosis; percutaneous coronary intervention; stable angina; unprotected left main coronary artery disease.
© 2021 Lucian Predescu et al., published by Sciendo.
References
REFERENCES
-
- 1. LEE MS, BOKHOOR P, PARK SJ, KIM YH, STONE GW, SHEIBAN I, et al. Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention. JACC Cardiovascular interventions. 2010; 3(8):791–5.
-
- 2. PALMERINI T, SANGIORGI D, MARZOCCHI A, TAMBURINO C, SHEIBAN I, MARGHERI M, et al. Impact of acute coronary syndromes on two-year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents. The American journal of cardiology. 2010; 105(2):174–8.
-
- 3. CUTLIP DE, WINDECKER S, MEHRAN R, BOAM A, COHEN DJ, VAN ES GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007; 115(17):2344–51.
-
- 4. PURICEL S, ADORJAN P, OBERHANSLI M, STAUFFER JC, MOSCHOVITIS A, VOGEL R, et al. Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2011; 7(6):697–704.
-
- 5. PARK SJ, KIM YH. Percutaneous coronary intervention for unprotected left main coronary artery stenosis. Cardiol Clin. 2010; 28(1):81–95.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous